ABBVIE INC (ABBV) Fundamental Analysis & Valuation
NYSE:ABBV • US00287Y1091
Current stock price
208.84 USD
-6.14 (-2.86%)
At close:
208.268 USD
-0.57 (-0.27%)
After Hours:
This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABBV Profitability Analysis
1.1 Basic Checks
- In the past year ABBV was profitable.
- In the past year ABBV had a positive cash flow from operations.
- ABBV had positive earnings in each of the past 5 years.
- ABBV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of ABBV (3.12%) is better than 89.36% of its industry peers.
- The Return On Invested Capital of ABBV (14.42%) is better than 95.94% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ABBV is significantly below the industry average of 27.17%.
- The last Return On Invested Capital (14.42%) for ABBV is above the 3 year average (12.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- The Profit Margin of ABBV (6.84%) is better than 89.56% of its industry peers.
- In the last couple of years the Profit Margin of ABBV has declined.
- With an excellent Operating Margin value of 34.23%, ABBV belongs to the best of the industry, outperforming 96.52% of the companies in the same industry.
- In the last couple of years the Operating Margin of ABBV has grown nicely.
- Looking at the Gross Margin, with a value of 71.62%, ABBV belongs to the top of the industry, outperforming 81.43% of the companies in the same industry.
- In the last couple of years the Gross Margin of ABBV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. ABBV Health Analysis
2.1 Basic Checks
- ABBV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- ABBV has about the same amout of shares outstanding than it did 1 year ago.
- ABBV has about the same amout of shares outstanding than it did 5 years ago.
- The debt/assets ratio for ABBV is higher compared to a year ago.
2.2 Solvency
- ABBV has an Altman-Z score of 2.30. This is not the best score and indicates that ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.30, ABBV is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
- The Debt to FCF ratio of ABBV is 3.79, which is a good value as it means it would take ABBV, 3.79 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.79, ABBV belongs to the top of the industry, outperforming 91.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.3 |
ROIC/WACC1.65
WACC8.74%
2.3 Liquidity
- A Current Ratio of 0.67 indicates that ABBV may have some problems paying its short term obligations.
- The Current ratio of ABBV (0.67) is worse than 89.17% of its industry peers.
- A Quick Ratio of 0.56 indicates that ABBV may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.56, ABBV is doing worse than 89.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. ABBV Growth Analysis
3.1 Past
- ABBV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
- ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
- ABBV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.57%.
- ABBV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.95% yearly.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
- The Revenue is expected to grow by 6.43% on average over the next years.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. ABBV Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 20.88, which indicates a rather expensive current valuation of ABBV.
- 92.84% of the companies in the same industry are more expensive than ABBV, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 25.60. ABBV is around the same levels.
- ABBV is valuated correctly with a Price/Forward Earnings ratio of 14.07.
- ABBV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABBV is cheaper than 96.13% of the companies in the same industry.
- ABBV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.88 | ||
| Fwd PE | 14.07 |
4.2 Price Multiples
- 94.20% of the companies in the same industry are more expensive than ABBV, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, ABBV is valued cheaply inside the industry as 95.36% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.73 | ||
| EV/EBITDA | 14.75 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ABBV has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%
5. ABBV Dividend Analysis
5.1 Amount
- ABBV has a Yearly Dividend Yield of 3.28%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.28, ABBV pays a better dividend. On top of this ABBV pays more dividend than 99.23% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.88, ABBV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
5.2 History
- The dividend of ABBV is nicely growing with an annual growth rate of 6.76%!
- ABBV has been paying a dividend for at least 10 years, so it has a reliable track record.
- ABBV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.76%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- 278.48% of the earnings are spent on dividend by ABBV. This is not a sustainable payout ratio.
- The dividend of ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
ABBV Fundamentals: All Metrics, Ratios and Statistics
208.84
-6.14 (-2.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-24 2026-04-24/bmo
Inst Owners76.17%
Inst Owner Change2.22%
Ins Owners0.06%
Ins Owner Change6.1%
Market Cap369.26B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.44
Price Target256.47 (22.81%)
Short Float %1.42%
Short Ratio3.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-15 2026-04-15 (1.73)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.31%
PT rev (3m)2.69%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)-3.62%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.1%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.88 | ||
| Fwd PE | 14.07 | ||
| P/S | 6.04 | ||
| P/FCF | 20.73 | ||
| P/OCF | 19.4 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.75 |
EPS(TTM)10
EY4.79%
EPS(NY)14.84
Fwd EY7.11%
FCF(TTM)10.08
FCFY4.82%
OCF(TTM)10.76
OCFY5.15%
SpS34.59
BVpS-1.85
TBVpS-51.78
PEG (NY)0.43
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.3 |
F-Score8
WACC8.74%
ROIC/WACC1.65
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / ABBV Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
What is the valuation status for ABBV stock?
ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.
What is the profitability of ABBV stock?
ABBVIE INC (ABBV) has a profitability rating of 7 / 10.
What is the valuation of ABBVIE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 20.88 and the Price/Book (PB) ratio is -112.92.
Is the dividend of ABBVIE INC sustainable?
The dividend rating of ABBVIE INC (ABBV) is 7 / 10 and the dividend payout ratio is 278.48%.